Latest NeuroSigma Inc. Stories
Treatment of Lennox-Gastaut with External Trigeminal Nerve Stimulation LOS ANGELES, Jan. 6, 2015 /PRNewswire/ -- NeuroSigma®, Inc.
Double-Blind Controlled Clinical Trial Opens Enrollment at the UCLA Semel Institute LOS ANGELES, Jan. 5, 2015 /PRNewswire/ -- NeuroSigma®, Inc.
Randomized Controlled Trial Conducted at the Santa Casa de Sao Paulo School of Medicine in Brazil LOS ANGELES, Nov.
LOS ANGELES, Nov. 17, 2014 /PRNewswire/ -- NeuroSigma®, Inc.
LOS ANGELES, Nov. 3, 2014 /PRNewswire/ -- NeuroSigma(®), Inc.
Subcutaneous Trigeminal Nerve Stimulation (sTNS) for the Treatment of Neuropsychiatric Disorders LOS ANGELES, Oct. 21, 2014 /PRNewswire/ - NeuroSigma(®), Inc.
Phase 1 Clinical Trial - External Trigeminal Nerve Stimulation for Traumatic Brain Injury LOS ANGELES, Oct. 15, 2014 /PRNewswire/ -- NeuroSigma(®), Inc.
LOS ANGELES, Aug.
LOS ANGELES, Aug. 25, 2014 /PRNewswire/ -- NeuroSigma, Inc.
LOS ANGELES, July 22, 2014 /PRNewswire/ -- NeuroSigma, Inc.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.